What are GLP-1, GLP-2, GIP Terms: A Simple Guide
Author
glp winnerDate Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link
GLP-1, GLP-2, and GIP are natural hormones in your body, and today’s medications are designed to copy or activate some of them to treat diabetes and obesity.
If you feel like the industry suddenly started speaking in code, you are not alone. GLP-1. GLP-2. GIP. Dual agonists. Incretins. It sounds technical. It is actually simpler than it looks.
Let’s break it down in plain language.
At GLP Winner, we focus on helping you understand what each medication actually does before you compare providers. Finding the right provider for you is our mission, and sharing all the information needed so you can make a good choice is our first step. Answer a few questions to get started here and see your personal provider list.
First, What Does “GLP” Even Mean?
GLP stands for glucagon-like peptide. That is just the scientific name for a hormone your gut releases after you eat (Cleveland Clinic). This controls how full you feel after eating, among other things your body does. It can change how your body responds to food.
Hormones are chemical messengers. They tell parts of your body what to do.
Different GLPs do different jobs, which is where you get so many terms from. We’ll break down what each of the GLP’s mean, and what it means when you hear GIP, too.
What Is GLP-1?
GLP-1 is the most commonly understood term when we talk about medications today. GLP-1 is a hormone that:
- Helps your body release insulin
- Lowers blood sugar
- Slows how quickly food leaves your stomach
- Helps you feel full
That is why GLP-1 receptor agonists, which are medicines that activate the GLP-1 receptor, are used for type 2 diabetes and chronic weight management (Cleveland Clinic).
For example, Ozempic is an FDA-approved medicine that contains semaglutide, a GLP-1 receptor agonist (Ozempic Prescribing Information).
Wegovy is also FDA-approved and contains semaglutide, a GLP-1 receptor agonist (Wegovy Prescribing Information).
When people say “I’m on a GLP-1,” this is usually what they mean.
What this means for you: GLP-1 medicines mainly affect appetite, digestion, and blood sugar.
What Is GIP?
GIP stands for glucose-dependent insulinotropic polypeptide. It is another hormone your body releases after eating (National Library of Medicine).
GIP also helps regulate insulin and blood sugar.
Some newer medications activate both GLP-1 and GIP receptors. These are called dual GIP/GLP-1 receptor agonists.
Mounjaro is an FDA-approved medicine that contains tirzepatide, a dual GIP/GLP-1 receptor agonist (Mounjaro Prescribing Information).
Zepbound is also FDA-approved and contains tirzepatide, a dual GIP/GLP-1 receptor agonist (Zepbound Prescribing Information).
In simple terms, these medicines activate two hormone pathways instead of one.
What this means for you: dual medicines may have slightly different effects because they work on two signals in the body instead of just GLP-1 alone. Sometimes, people’s bodies respond more effectively to these types of combinations over just a GLP-1. It doesn’t always mean it’s the best medication for you just because it does more, but it is an option to consider when speaking with your provider.
What Is GLP-2?
GLP-2 is another hormone your gut releases after eating. Its main role is helping maintain the lining of the intestines and supporting nutrient absorption (National Library of Medicine).
GLP-2 is not used for weight management.
There are GLP-2-based medicines, but they are used for rare intestinal conditions, not diabetes or obesity.
When you hear GLP-2 in conversation about weight loss, it is usually confusion or marketing noise. Sometimes you’ll see GLP II or GLP-2 in grey market peptides as a marketing term. It’s important to understand what this actually means, and know that when you see this it is likely a scam.
What this means for you: GLP-2 is not part of current obesity treatment medications, be wary of any company offering these as an alternative to semaglutide or tirzepatide.
What Are “GLP-3s”?
There is no approved hormone called GLP-3 used in clinical obesity treatment.
Sometimes people use “GLP-3” casually to describe next-generation triple-agonist drugs in development. These investigational medicines aim to activate three hormone pathways at once, such as GLP-1, GIP, and glucagon receptors (National Library of Medicine).
These are still in research phases and are not currently FDA-approved for public use.
What this means for you: if you hear “GLP-3,” it usually refers to experimental or future therapies, not something currently available. GLP-3 is sometimes used as a marketing term in grey market or unsafe compounding options, but if you see it, you should immediately be wary of safety and what is actually being sold to you.
What Does “Incretin-Based Medicine” Mean?
“Incretin” is the umbrella term for hormones like GLP-1 and GIP that are released after eating and help regulate blood sugar (American Diabetes Association).
So when you see “incretin-based therapy,” it simply means medicines that activate GLP-1, GIP, or both.
It sounds technical. It just means hormone-based metabolic treatment.
Where Do Compounded Options Fit In?
You may also hear about compounded GLP-1 or GLP-1/GIP products.
Compounded medications are customized formulations prepared by licensed pharmacies under federal law when a prescriber determines a patient has a specific medical need (FDA Compounding Overview).
Compounded GLP-1 products are not FDA-approved finished drugs, and the FDA says companies cannot market them as “generic” or “the same as” FDA-approved drugs (FDA Enforcement Statement).
Some patients and clinicians consider compounded options when individualized dosing adjustments or formulation preferences are medically appropriate. These decisions should always be made with a licensed clinician, and medications should be sourced from properly licensed and, when applicable, FDA-inspected facilities.
Understanding the regulatory difference helps you compare options more clearly.
Because being specific matters when you’re talking about medications, sometimes you’ll hear compounded medications referred to as their specific mechanism, such as compounded semaglutide also being called GLP-1, or compounded tirzepatide being referred to as GIP/GLP-1.
Final Takeaway
When you strip away the abbreviations, this all becomes much simpler. GLP-1 and GIP are hormones your body already makes to help manage blood sugar and appetite. The medications you hear about are designed to use those same pathways to support people with diabetes or obesity.
GLP-2 is different. It mainly helps support the lining of the intestines and is not part of weight management treatment. And when someone says “GLP-3,” they are usually talking about experimental drugs still being studied, not something currently approved or available.
Once you understand what each term actually refers to, the jargon loses its edge. It becomes easier to see what is real, what is in development, and what might apply to you right now.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Sources
Keep Reading
Hearing new GLP-1 names? Learn why language changed, what stayed the same, and how to tell if your medication actually changed.
What does GLP-1/GIP mean? Learn how dual GIP/GLP-1 medications differ from GLP-1 drugs and why terminology is changing.
Learn common GLP-1 terms like semaglutide, tirzepatide, FDA-approved, off-label, and compounded in plain English with trusted sources.
Categories
Curated by
